Other potential mechanisms of TGF-β-mediated immunosuppression include platelet-derived TGF-β-mediated production of IL-6 by hepatic endothelial cells [125], which, in turn, promotes increased production of thrombopoietin [126], driving thrombocytosis and platelet activation. Here, TGFB1 is linked to thrombocytosis disease.